New research from Harvard University suggests a link between GLP-1 weight-loss medications and improved social and economic outcomes for women.
Economist Rebecca Diamond analyzed survey data from the University of Southern California, comparing women who began GLP-1s for weight loss to those who had not. The study focused exclusively on women, who are more likely to use these drugs than men.
The findings indicate that women who successfully lost weight experienced significant changes in key life areas. For single women, rates of marriage or cohabitation increased by 29% after about 18 months. Among women who were unemployed at the study's start, job prospects rose by 27% over the same period.
Experts not involved in the study provided context. Dr. Peter Balazs, a weight-loss specialist, noted the effects appeared in 'new match' situations like job interviews or dating, not in existing relationships or careers. He stated this speaks more to societal bias than the medication itself.
Dr. Krishna Vyas, a plastic surgeon, observed that many patients seek procedures after major weight loss to "re-engage with life." He highlighted that while opportunities increased, the study showed no clear improvement in measures like depression or life satisfaction, suggesting the change may come from external gatekeepers.
The research has limitations. It is an observational study, showing association but not causation, and the paper has not yet been peer-reviewed. All data was self-reported. Experts called for further study that includes men to see if the results hold true across genders.